| Autor: |
Harland LTG; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Simon CS; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Senft AD; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.; National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA., Costello I; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Greder L; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Imaz-Rosshandler I; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK., Göttgens B; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Marioni JC; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.; Wellcome Sanger Institute, Cambridge, UK.; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Bikoff EK; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Porcher C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., de Bruijn MFTR; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK. marella.debruijn@imm.ox.ac.uk., Robertson EJ; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. elizabeth.robertson@path.ox.ac.uk. |
Full text from SpringerLink